Krti Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 26-12-2024
- Paid Up Capital ₹ 4.77 M
as on 26-12-2024
- Company Age 32 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.43 M
as on 26-12-2024
- Satisfied Charges ₹ 4.00 M
as on 26-12-2024
- Revenue -50.51%
(FY 2016)
- Profit 69.93%
(FY 2016)
- Ebitda -1088.43%
(FY 2016)
- Net Worth -0.88%
(FY 2016)
- Total Assets 19.05%
(FY 2016)
About Krti Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 4.77 M.
The company currently has active open charges totaling ₹2.43 M. The company has closed loans amounting to ₹4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Danish Sukumaran, Ramkumar Menon, Kunnampath Sukumaran, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24231KL1992PLC006849
- Company No.
006849
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Dec 1992
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- LocationTrichur, Kerala
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Krti Lifescience Limited offer?
Krti Lifescience Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Diabetes Medicine.
Who are the key members and board of directors at Krti Lifescience?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kunnampath Sukumaran  | Managing Director | 21-Jan-2003 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramkumar Menon | Director | 29-Jan-2016 | Current |
| Danish Sukumaran | Director | 21-Jan-2003 | Current |
| Vimala Sukumaran | Director | 21-Jan-2001 | Current |
| Divya Sukumaran | Director | 21-Jan-2001 | Current |
Financial Performance of Krti Lifescience.
Krti Lifescience Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 50.51% decrease. The company also saw a substantial improvement in profitability, with a 69.93% increase in profit. The company's net worth dipped by a decrease of 0.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Krti Lifescience?
In 2017, Krti Lifescience had a promoter holding of 85.20% and a public holding of 14.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Erutan Tourism Company Private LimitedActive 18 years 11 monthsDanish Sukumaran, Kunnampath Sukumaran and 2 more are mutual person
- Divyaram Medical And Research Institute Private LimitedActive 7 years 25 days
Ramkumar Menon, Kunnampath Sukumaran and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The South Indian Bank Ltd. Creation Date: 26 Mar 1999 | ₹0.43 M | Open |
The South Indian Bank Ltd. Creation Date: 05 Nov 1997 | ₹1.20 M | Open |
The South Indian Bank Ltd. Creation Date: 10 May 1997 | ₹0.60 M | Open |
How Many Employees Work at Krti Lifescience?
Krti Lifescience has a workforce of 5 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krti Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krti Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
